DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Baselga J, Bradbury I, Eidtmann H. et al.
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Lancet 2012;
379: 633-640

Download Bibliographical Data

Access:
Access: